Protalix Biotherapeutics Inc (PLX)
Healthcare
Biotechnology
2.30 $
-2.1%
vs. previous close
Closing price · As of: 3. Aug 2026
Protalix Biotherapeutics Inc (PLX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -12 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -29 | -24 | -32 | -10.0 | -7.7 | -19 | -26 | -10 | -25 | -1.3 | 8.7 | -12 | |
| 3.1 | 2.4 | 2.0 | 1.9 | 1.7 | 1.6 | 1.3 | 1.1 | 1.1 | 1.2 | 1.3 | 1.5 | |
| 1.2 | 1.8 | 1.0 | 0.3 | 0.5 | 0.8 | 3.1 | 2.4 | 2.1 | 3.4 | 3.3 | 2.3 | |
| 0.5 | 3.5 | -6.4 | 42 | 0.5 | 0.8 | 2.8 | 3.6 | 0.6 | – | – | – | |
| -5.7 | -3.3 | 1.1 | 29 | 14 | -6.8 | -27 | 9.9 | -12 | -11 | 0.8 | -10 | |
| 0.8 | 0.5 | 0.8 | 1.0 | 0.7 | 0.6 | 0.7 | 1.5 | 0.6 | 1.1 | 1.3 | 1.6 | |
| -1.0 | 39 | -1.0 | -1.1 | -0.6 | -0.9 | -20 | 19 | -5.0 | -17 | 4.2 | -2.4 | |
| 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | |
| 0.0 | 0.5 | 0.0 | 0.0 | – | – | 47 | 46 | 8.2 | 25 | 3.6 | 9.3 | |
| 20 | 20 | 20 | -1.4 | -4.8 | -0.2 | -0.2 | -34 | 0.0 | 0.0 | -20 | 0.0 | |
| 0.0 | 6.6 | 20 | -1.4 | -4.8 | 46 | 46 | 12 | 8.2 | 25 | -17 | 9.3 | |
| -32 | 22 | -13 | -12 | -13 | -20 | 0.5 | 21 | -22 | 6.5 | -3.9 | -4.4 | |
| -30 | -25 | -33 | -11 | -8.4 | -20 | -27 | -12 | -26 | -2.5 | 7.4 | -14 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.